Bio-Rad Laboratories Class A
271 hedge funds and large institutions have $4.27B invested in Bio-Rad Laboratories Class A in 2017 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 81 increasing their positions, 119 reducing their positions, and 33 closing their positions.
117% more call options, than puts
Call options by funds: $2.8M | Put options by funds: $1.29M
1.45% more ownership
Funds ownership: 76.8% → 78.25% (+1.4%)
0% more capital invested
Capital invested by funds: $4.26B → $4.27B (+$9.01M)
9% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 33
2% less funds holding
Funds holding: 276 → 271 (-5)
32% less repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 119
40% less funds holding in top 10
Funds holding in top 10: 10 → 6 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
American Century Companies
Kansas City,
Missouri
|
+$127M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$38.3M |
| 3 |
PC
Polar Capital
London,
United Kingdom
|
+$30.4M |
| 4 |
SC
Samlyn Capital
New York
|
+$25.9M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
+$22.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$124M |
| 2 |
AA
Antipodean Advisors
New York
|
-$17M |
| 3 |
ACM
Atlanta Capital Management
Atlanta,
Georgia
|
-$16.1M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$15M |
| 5 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
-$13.3M |
BIO Hedge Fund Activity: Q3 2017 in Review
271 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q3 2017, worth a combined $4.27B — up 0.21% from $4.26B a quarter earlier.
Sellers outnumbered buyers: 33 funds closed out of BIO and 30 opened new positions — a net loss of 3 holders — while 119 trimmed existing stakes and 81 added.
The largest buyer was American Century Companies, opening a new position worth an estimated $127M. The largest seller was Fidelity Investments, cutting an estimated $124M.
- 271 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q3 2017, down from 276 in Q2 2017.
- Funds reported $4.27B of Bio-Rad Laboratories Class A stock for Q3 2017, up 0.21% quarter-over-quarter.
- 30 funds opened new Bio-Rad Laboratories Class A positions in Q3 2017 and 33 closed out, a net change of -3 holders.
- The largest Bio-Rad Laboratories Class A buyer in Q3 2017 was American Century Companies, an estimated $127M added.
- The largest Bio-Rad Laboratories Class A seller in Q3 2017 was Fidelity Investments, an estimated $124M sold.
Based on aggregated 13F filings for Q3 2017.